Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normocholesterolemic patients undergoing coronary stenting: A randomized study with intravascular ultrasound

American Heart Journal

Volumn 149, Issue 3, 2005, Pages 520-526

  Petronio, Anna Sonia ^a   Amoroso, Giovanni ^a,b   Limbruno, Ugo ^a   Papini, Barbara ^a   De Carlo, Marco ^a   Micheli, Andrea ^a   Ciabatti, Nicola ^a   Mariani, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

^b CISANELLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SIMVASTATIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DRUG EFFICACY; EVALUATION; FEMALE; HEART INFARCTION; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 17844411464     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.10.032     Document Type: Article

References (32)

1. P.W. Serruys, P. de Jaegere, and F. Kiemeneij A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group N. Engl. J. Med. 331 1994 489 495
2. D.L. Fischman, M.B. Leon, and D.S. Baim A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. The Stent Restenosis Study Investigators N. Engl. J. Med. 331 1994 496 501
3. R. Hoffmann, G.S. Mintz, and G.R. Dussaillant Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study Circulation 94 1996 1247 1254
4. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N. Engl. J. Med. 349 2003 1315 1323
5. G.W. Stone, S.G. Ellis, and D.A. Cox One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial Circulation 109 2004 1942 1947
6. M. Degertekin, E. Regar, and K. Tanabe Evaluation of coronary remodelling after sirolimus-eluting stent implantation by serial three-dimensional intravascular ultrasound Am. J. Cardiol. 91 2003 1046 1050
7. A. Schomig, J. Mehilli, and H. Holle Statin treatment following coronary artery stenting and one-year survival J. Am. Coll. Cardiol. 40 2002 854 861
8. P. Libby, and M. Aikawa Mechanisms of plaque stabilization with statins Am. J. Cardiol. 91 2003 4B 8B
9. A. Corsini, M. Raiteri, and M.R. Soma Simvastatin but not pravastatin has a direct inhibitory effect on rat and human myocyte proliferation Clin. Biochem. 25 1992 399 400
10. W.S. Weintraub, S.J. Boccuzzi, and J.L. Klein Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group N. Engl. J. Med. 331 1994 1331 1337
11. D.H. Walter, V. Schachinger, and M. Elsner Effect of statin therapy on restenosis after coronary stent implantation Am. J. Cardiol. 85 2000 962 968
12. E.J. Topol, and S.E. Nissen Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease Circulation 92 1995 2333 2342
13. D.H. Walter, V. Schachinger, and M. Elsner Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the Pl(A2) allele of the platelet glycoprotein IIIa gene Eur. Heart J. 22 2001 587 595
14. P.A. Lemos, A. Hoye, and D. Goedhart Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) study Circulation 109 2004 1366 1370
15. J.W. Jukema, A.V. Bruschke, and A.J. van Boven Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS) Circulation 91 1995 2528 2540
16. K. Ishikawa, S. Tani, and I. Watanabe Effect of pravastatin on coronary plaque volume Am. J. Cardiol. 92 2003 975 977
17. S.E. Nissen, E.M. Tuzcu, and P. Schoenhagen Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial JAMA 291 2004 1071 1080
18. L.O. Jensen, P. Thayssen, and K.E. Pedersen Regression of coronary atherosclerosis by simvastatin. A serial intravascular ultrasound study Circulation 110 2004 265 270
19. S. Okazaki, T. Yokoyama, and K. Miyauchi Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study Circulation 110 2004 1061 1068
20. A. Corsini, S. Bellosta, and R. Baetta New insights into the pharmacodynamic and pharmacokinetic properties of statins Pharmacol. Ther. 84 1999 413 428
21. M. Schartl, W. Bocksch, and D.H. Koschyk For the German Atorvastatin Intravascular Ultrasound Study Investigators (GAIN) use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease Circulation 104 2001 387 392
22. M. Crisby, G. Nordin-Fredriksson, and P.K. Shah Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization Circulation 103 2001 926 933
23. R. Virmani, F.D. Kolodgie, and A. Farb Drug eluting stents: are human and animal studies comparable? Heart 89 2003 133 138
24. A. Farb, G. Sangiorgi, and A.J. Carter Pathology of acute and chronic coronary stenting in humans Circulation 99 1999 44 52
25. M.A. Costa, A.G.M.R. Sousa, and A.C. Abizaid Two-year angiographic and intravascular ultrasound follow-up after implantation of Sirolimus-eluting stents in human coronary arteries Circulation 107 2003 381 383
26. F. Alfonso, P. Garcia, and G. Pimentel Predictors and implications of residual plaque burden after coronary stenting: an intravascular ultrasound study Am. Heart J. 145 2003 254 261
27. Terumo-statin releasing stent-rationale and animal results Available at: http://www.tctmd.com/expert-presentations/table-2.html?product_id=3666 TCT 2002
28. C.P. Cannon, E. Braunwald, and C. McCabe Intensive versus moderate lipid lowering with statins after acute coronary syndromes N. Engl. J. Med. 350 2004 1495 1504
29. V. Pasceri, G. Patti, and A. Nusca Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study Circulation 110 2004 674 678
30. A.W. Chan, D.L. Bhatt, and D.P. Chew Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention Circulation 105 2002 691 696
31. Heart Protection Study Collaborative Group MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
32. J.A. Staffa, J. Chang, and L. Green Cerivastatin and reports of fatal rhabdomyolysis N. Engl. J. Med. 346 2002 539 540